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INTRODUCTION 
Renal cell carcinoma with TFEB gene rearrangement was originally recognized 
based on translocation t(6;11) occurring in children.[1] The unique histologic appearance 
of these tumors was first characterized as including large cells with clear or eosinophilic 
cytoplasm and a second population of smaller cells with scant cytoplasm arranged around 
hyaline basement membrane material, resembling rosettes.[1,2] More recently, however, 
other studies have found that this unique morphology is not always straightforward, and 
that some molecularly-confirmed TFEB rearrangement tumors may mimic clear cell renal 
cell carcinoma, chromophobe renal cell carcinoma, tubulocystic renal cell carcinoma, 
epithelioid angiomyolipoma, multilocular cystic renal cell carcinoma, or high-grade 
unclassified renal cell carcinoma.[3-6] One recent series included a single example that 
was extensively hyalinized and ossified.[4] Herein we report another such example with 
extensive sclerosis and metaplastic bone formation, nearly obscuring the epithelial nature 
of the tumor, suggesting that this tendency for sclerosis may be a recurring pattern of 
TFEB renal cell carcinoma.  
MATERIALS AND METHODS 
Immunohistochemistry 
Antibodies directed against α-methylacyl-coA-racemase (AMACR/P504S (13H4; 
Dako Corp, Carpinteria, CA, USA), carbonic anhydrase IX (polyclonal rabbit; Abcam, 
Cambridge, UK), cathepsin K (3F9; Abcam), CD10 (56C6; Dako Corp), cytokeratin 
(AE1/AE3; Dako Corp), cytokeratin 7 (CK7) (OV-TL 12/30; Dako Corp), caldesmon (h-
CD; Dako Corp), epithelial membrane antigen (EMA; E29; Dako), human melanosome 
(HMB45; Dako Corp), inhibin (R1; Dako Corp), melan-A (A103; Dako Corp), PAX8 
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(polyclonal; Cell Marque, Rocklin, CA, USA), smooth muscle actin (1A4 clone; Dako 
Corp), TFE3 (MRQ-37; Cell Marque), and vimentin (V9; Dako Corp) were utilized in a 
Dako automated instrument. Positive and negative controls yielded appropriate results for 
each antibody. 
Fluorescence in situ hybridization (FISH) 
Bacterial artificial chromosome (BAC) clones from the immediately flanking 
genomic regions of TFEB and TFE3 genes were used to generate dual color break-apart 
FISH probes (TFEB: RP11-246A15- 5’, RP11-624F22-3’; TFE3: RP11-528A24,-5’, 
RP11-416B14-3’). BAC clones were tested on normal human metaphase chromosomes to 
validate map position.  Probes were detected with anti-digoxigenin fluorescein Fab 
fragments to yield green color and Streptavidin Alexa fluor 594 to yield red color for the 5’ 
and 3’ probes respectively.  Overnight 200 ml cultures for each BAC clone were grown in 
LB medium containing 12.5g/ml of chloramphenicol at 37C for 14-16 hours with 
constant shaking.  DNA was prepared using Qiagen-midiprep kit using Qiatip-100 
according to the protocol provided by the manufacturer (Qiagen, Hilden, Germany). 
All FISH probes were prepared by nick translation labeling using modified 
nucleotides conjugated with biotin or digoxigenin utilizing biotin nick translation mix 
(11745824910, Roche, Basel, Switzerland) and digoxigenin nick translation mix 
(11745816910, Roche) for 3’ and 5’ probes respectively.  Probe DNA was precipitated and 
dissolved in hybridization mixture containing 50% formamide, 2XSSC, 10% dextran 
sulphate, and 1% Denhardt’s solution.  Approximately 200ng of each labeled probe was 
used for hybridization. Fluorescent signals were detected with Streptavidin Alexa fluor 594 
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(S-32356, Invitrogen, Carlsbad, CA, USA) and anti-digoxigenin fluorescein Fab fragments 
(11207741910, Roche) for red and green colors, respectively. 
CASE REPORT 
 A 54 year-old woman found to have an endophytic, enhancing renal mass in the 
right kidney (Figure 1A). Partial nephrectomy was performed, and the specimen was 
evaluated by two of the authors (SRW and JNE) for classification of the extensively 
sclerotic and calcified renal mass, measuring 2.4 x 1.5 x 1.5 cm. Histologic sections 
revealed predominant fibrosis, hyalinization, calcification and ossification (Figure 1B). 
Adipose tissue was focally present, adjacent to the areas of bone formation, likely 
representing metaplastic formation of bone marrow. Occasional thick-walled blood vessels 
were also present (Figure 1B), raising consideration of an unusual pattern of 
angiomyolipoma. A minority of the neoplasm was composed of aggregates of epithelioid 
cells with variably clear to eosinophilic, vacuolated cytoplasm forming solid sheets and 
focally cysts (Figure 1C-D). The nuclei of these cells were round and uniform, although 
with focally moderate variability in nuclear size (Figure 1D). Rare cells revealed multiple 
nuclei arranged around a central eosinophilic area, with peripheral vacuolization of the 
cytoplasm, similar to epithelioid cells that have been reported in angiomyolipoma. Based 
on these findings, immunohistochemical staining to evaluate a differential diagnosis 
including sclerotic renal cell carcinoma, angiomyolipoma, and renal hemangioblastoma 
was undertaken.  
 Immunohistochemical staining revealed the epithelioid cells to be positive diffusely 
for cytokeratin AE1/AE3 (Figure 2A, 90% of recognizable epithelioid cells) and PAX8 
(Figure 2B, at least 90% of recognizable epithelioid cells) and negative for caldesmon, 
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SMA, TFE3 protein, carbonic anhydrase IX, CD10, CK7, EMA and inhibin. Variable 
labeling for melan-A (Figure 2C, 5-10% of cells) and cathepsin K (Figure 2D, 50-60% of 
cells) was present in the epithelioid component, and antibodies to HMB-45 (Figure 2E) 
and AMACR (p504s) labeled rare cells (1% of cells or less). Fluorescence in situ 
hybridization revealed rearrangement (split signals) for TFEB (Figure 2F) and no 
rearrangement of TFE3. 
 
DISCUSSION 
 Renal cell carcinoma with TFEB rearrangement is now regarded as part of a group 
of related tumors with Xp11.2 translocation carcinoma (TFE3 translocation renal cell 
carcinoma), together considered the microphthalmia transcription factor (MITF) 
rearrangement family of tumors.[7,8] Although initially recognized based on distinctive 
histology (biphasic cell populations with large clear or eosinophilic cells and small cells 
with scant cytoplasm and hyaline material) in children,[1] it has been more recently shown 
that TFEB rearrangement-associated renal cell carcinoma also occurs in adults and that 
some tumors may not exhibit the prototypical biphasic cell populations, mimicking other 
subtypes of renal cell carcinoma.[3-6] 
 Deceptive patterns of TFEB translocation renal cell carcinoma that have been 
recently recognized include examples with multilocular cystic,[3] oncocytic,[4] 
eosinophilic papillary,[4] high-grade unclassified,[3,5] chromophobe renal cell carcinoma-
like,[5] tubulocystic,[6] epithelioid angiomyolipoma-like,[5] or clear cell-like[1,5] 
features. One example from a series of 8 tumors reported by Argani and colleagues was 
noted to be extensively sclerotic and ossified,[4] occurring in a 37 year-old man, similar to 
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the case reported here. Both in the report by Argani et al and the current case, the tumors 
yielded labeling for PAX8, melan-A, cathepsin K, and a lesser extent of labeling for 
HMB45, without the appreciable dual cell population pattern that is characteristic of TFEB 
translocation-associated tumors.[4] Thus, it appears that an extensively sclerotic histologic 
pattern, although likely less common than the prototypical appearance, potentially 
represents a recurring histology of TFEB rearrangement-associated renal cell carcinoma. 
Since this differs from the distinctive morphology originally reported, pathologists should 
be aware of this unusual phenomenon to facilitate diagnostic classification.  
 In this case, we were prompted to consider several differential diagnostic 
possibilities based on the unusual tumor histology: Clear cell renal cell carcinoma is the 
most common subtype of renal cell carcinoma, and therefore presumably the most likely to 
undergo extensive degenerative changes. In the current case, negative reactivity for 
carbonic anhydrase IX, combined with positive labeling for melanocytic markers (HMB45 
and melan-A) and cathepsin K[9] argued against a diagnosis of clear cell renal cell 
carcinoma and argued in favor of a translocation-associated tumor, which was confirmed 
by FISH. Due to the mixture of epithelioid clear to eosinophilic cells, thick blood vessels, 
and fat, we also considered the possibility of an unusual manifestation of angiomyolipoma. 
Calcification associated with fat in a renal mass is generally considered presumptive 
evidence for renal cell carcinoma radiographically,[10,11] most likely representing bone 
marrow fat associated with metaplastic bone.[10,12] However, rare calcification in 
angiomyolipoma has been reported.[10] Despite that positivity for melanocytic markers 
and cathepsin K would be a shared feature of both TFEB translocation renal cell carcinoma 
and angiomyolipoma, the tumor cells in this case were negative for smooth muscle 
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markers (smooth muscle actin, caldesmon) and positive for epithelial markers (keratin 
AE1/AE3 and PAX8), resolving this distinction. Finally, we also considered the possibility 
of hemangioblastoma, based on the composition by foamy-appearing cells with clear to 
eosinophilic cytoplasm. Although much more common in the central nervous system, 
hemangioblastoma has recently been increasingly recognized to occur as a primary renal 
tumor, and several studies have recently found unexpected aberrant positivity for 
PAX8.[13-15] Although few primary renal hemangioblastomas have been thoroughly 
characterized with a broad immunohistochemical panel, these tumors appear to be 
consistently positive for inhibin, and negative for melanocytic markers and cathepsin K, 
and predominantly negative for epithelial markers other than PAX8.[13-16] Interestingly, 
PAX2 and PAX8 have been found to show negative staining in central nervous system 
hemangioblastomas, supporting a role as diagnostic markers to distinguish 
hemangioblastoma from metastatic renal cell carcinoma, both of which are prone to occur 
in von Hippel-Lindau disease patients.[17] The aberrant PAX8 positivity in primary 
kidney hemangioblastomas has therefore been hypothesized to reflect origin from an 
organ-specific cell type through unknown mechanisms.[13,15] Conversely, inhibin 
positivity has also been reported in some renal cell carcinomas, blurring the distinction 
between renal cell carcinoma and hemangioblastoma of the kidney in some cases.[18,19] 
 In summary, here we report an example of extensively sclerotic and ossified renal 
cell carcinoma with TFEB rearrangement, which showed positive immunohistochemical 
labeling for keratin AE1/AE3 and PAX8, patchy labeling for melan-A and cathepsin K, 
and very limited labeling for HMB45. Combined with one prior such example from a 
series of TFEB rearrangement renal cell carcinomas, it appears that this may be a less 
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common but recurring histologic pattern of TFEB renal cell carcinoma, which can be 
distinguished from angiomyolipoma and other renal cell carcinoma subtypes via 
immunohistochemistry and molecular studies.  
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Figure Legends: 
Figure 1: (A) Computed tomography demonstrates a heterogeneously enhancing small 
endophytic renal mass in the right kidney (white arrow). (B) The tumor is composed of 
extensive sclerosis with metaplastic bone formation, adipose tissue and hyalinized, thick 
blood vessels (top, H&E 100x magnification). Higher magnification (C, H&E 200x 
magnification) reveals epithelial cells with clear to eosinophilic and foamy (D, H&E 400x 
magnification) cytoplasm and moderate variation in nuclear size. A distinct nested 
arrangement with delicate vascular network, as would be expected of clear cell renal cell 
carcinoma, is lacking. 
 
Figure 2: The epithelial cells label diffusely for keratin AE1/AE3 (A, 100x magnification) 
and PAX8 (B, 100x magnification). There is patchy reactivity for melan-A (C, 100x 
magnification) and cathepsin K (D, 100x magnification). Positivity for HMB45 is very 
limited compared to melan-A, with only rare scattered cells showing a positive reaction (E, 
arrows, 100x magnification and inset 200x magnification). Fluorescence in situ 
hybridization reveals rearrangement of TFEB (F, 1000x magnification), with one signal 
pair showing non-rearranged fused signals (white arrow) and the other signal pair being 
widely separated (black arrows).  
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ABSTRACT  
Renal cell carcinoma with TFEB rearrangement [t(6;11)(p21;q13)] was initially recognized 
to be composed of dual populations of large cells with clear cytoplasm and small cells 
forming rosettes around hyaline material. With increasing awareness, however, the 
spectrum of described morphology has been found to be more heterogeneous. We report a 
54 year-old woman who underwent partial nephrectomy for a 2.4 cm renal mass, 
composed of fibrosis, hyalinization, calcification and ossification, and a smaller 
component of epithelioid cells. Immunohistochemical staining revealed diffuse positivity 
for cytokeratin AE1/AE3 and PAX8, patchy labeling for melan-A, HMB45, and cathepsin 
K, and negative caldesmon, SMA, TFE3 protein, carbonic anhydrase IX, CD10, CK7, 
EMA and inhibin. Fluorescence in situ hybridization confirmed rearrangement of TFEB 
and not TFE3. Together with one recent case in another report, our findings suggest that 
extensive sclerosis and ossification may be a less common recurring histology of TFEB 
rearrangement renal cell carcinoma.   
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Figure 1 
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Figure 2 
